©The Author(s) 2025.
World J Gastrointest Endosc. Oct 16, 2025; 17(10): 108729
Published online Oct 16, 2025. doi: 10.4253/wjge.v17.i10.108729
Published online Oct 16, 2025. doi: 10.4253/wjge.v17.i10.108729
Table 1 Risk groups and incidence rates, as cases per 100000 person-years
| Risk groups | IRs |
| HIV-positive MSM > 60 years | 107.5 |
| HIV-positive MSM < 30 years | 16.8 |
| HIV-positive MSM | 85 |
| Non-MSM male PLHIV | 32 |
| Female PLHIV | 22 |
| HIV-negative MSM | 19 |
| Solid organ transplant recipients | 13 |
| SOTRs in males > 10 years after transplant | 24.5 |
| SOTRs in females > 10 years after transplant | 49.6 |
| Vulvar cancer | 48 |
| Vaginal cancer | 10 |
| Cervical cancer | 9 |
| Systemic lupus erythematous | 10 |
| Ulcerative colitis | 6 |
| Crohn’s disease | 3 |
- Citation: Gomes A, Bara J, da Matta CHKT, Paiva PP, de Carvalho LM, Bononi BM, Pinto PCC, Rodrigues JMS, Borghesi RA. Anal neoplasm in colonoscopy: What endoscopists need to know. World J Gastrointest Endosc 2025; 17(10): 108729
- URL: https://www.wjgnet.com/1948-5190/full/v17/i10/108729.htm
- DOI: https://dx.doi.org/10.4253/wjge.v17.i10.108729